Because PPARα has a therapeutic effect in DR and is neuroprotective in several disease models, it is reasonable to hypothesize that PPARα may be neuroprotective in retinopathy, which is characterized in part by neurodegeneration [4, 63, 64]. This evidence concerns the gene PPARA and retinal disorder.